Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
follicular lymphoma
Pharma
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
With the first follicular lymphoma nod for a BTK inhibitor, BeiGene's Brukinsa will go up against CAR-T cell therapies and bispecifics.
Angus Liu
Mar 7, 2024 4:08pm
ASH: Roche offers glimpse at Columvi-Polivy combo in DLBCL
Dec 11, 2023 7:00am
AbbVie, Genmab's Epkinly shows promise in follicular lymphoma
Jun 28, 2023 3:08pm
FDA signs off on Roche's Lunsumio to treat follicular lymphoma
Dec 27, 2022 10:27am
ASH: Roche braces for lymphoma bispecific war
Dec 11, 2022 6:30pm
Roche eyes year-end FDA bispecific verdict in lymphoma
Jul 6, 2022 10:15am